Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?

ISSN： 1172-7047

Source： CNS Drugs, Vol.10, Iss.3, 1998-09, pp. : 159-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sleep Attacks and Dopamine Agonists for Parkinsons Disease: What is Currently Known?

By Zesiewicz T.A. Hauser R.A.

CNS Drugs, Vol. 17, Iss. 8, 2003-01 ,pp. : 593-600

Adis International

Access to resources Recommend Favorite

Treatment of Parkinsons Disease: Whats on the Horizon?

By Wu Stacy S.

CNS Drugs, Vol. 19, Iss. 9, 2005-01 ,pp. : 723-743

Adis International

Access to resources Recommend Favorite

Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 908-926

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron Jankovic Joseph

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?

By Le W-D. Jankovic J.

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite